2019 Winter Meeting
New England Drug Metabolism Discussion Group
Location: Date/Time:
TAKEDA PHARMACEUTICALS COMPANY, 35 LANDSDOWNE STREET, CAMBRIDGE, MA
02139
12/5/2019 
5:30 p.m. - 9:00 p.m.
Contact Information: Other Info:
sirimas.sudsakorn@sanofi.com Click to view more info about the event
 Details

The New England

DRUG METABOLISM DISCUSSION GROUP

 

Winter Quarterly Meeting


Thursday, December 5th, 2019

TAKEDA PHARMACEUTICALS COMPANY,
35 Landsdowne Street, Cambridge, MA 02139

($5 Parking voucher valid at 80 Landsdowne Street garage available for purchase online)

 

Entitled

The Drug Metabolism Scientist’s Contribution to the Development of Gene Therapies: It’s not what you do, it’s the way that you do it


Speaker

Mark Milton,Ph.D.

Executive Director, PK Sciences, Global Head Ophthalmology TA,
Novartis Institutes for BioMedical Research, Inc.

 

Abstract
Although in vivo, viral-based, Gene Therapies have been studies by academia for many decades it is only in the past 5-10 years that a significant number of these therapies have entered Clinical trials under the sponsorship of Biotech and Pharmaceutical companies.  The involvement of these companies in the development of in vivo Gene Therapies has required the drug metabolism scientists to adapt the approaches and mindsets that have served them well for developing LMW and Biologics.  This presentation will provide an overview of what a traditional DMPK organization can contribute to the development of a Gene Therapy, describe how that support is currently provided, and offer insights into alternative, and hopefully better, ways of providing that support.

The cocktail hour will begin at 5:30 PM, dinner at 6:30 PM and the presentation at 7:30 PM.


If you need a 'Special Food Request' contact:

Sirimas.sudsakorn@sanofi.com


The deadline for reservations or cancellations is 4pm, December 2nd, 2019


********NO WALK-IN OR LATE REGISTRATION ACCEPTED********